Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaolai Zhou

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinomaMin Li, Yuxiao Tang, Dongyao Wang, et al.
Cancer Letters|April 20, 2024
Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinomaSongyang Yu, Sheng Su, Pengcheng Wang, et al.
Cell Death & Disease|May 12, 2018
microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7AChubin Luo, Dan Yin, Hao Zhan, et al.
Nucleic Acids Research|May 23, 2024
rAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombinationChen Ling, Chenghui Yu, Cong Wang, et al.
Hepatology (Baltimore, Md.)|December 26, 2024
LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinomaRongqi Sun, Kaixuan Liu, Siyuan Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2018
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled StudyZheng Wang, Zhenggang Ren, Yi Chen, et al.
Lancet (London, England)|October 22, 2025
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trialZheng Wang, Jia Fan, Shaolai Zhou, et al.
Gut|December 13, 2025
CD177<sup>+</sup> neutrophils drive extracellular matrix remodelling and HGF-alpha release in ALPPS-induced liver regenerationJiayan Yan, Ao Huang, Shiyu Zhang, et al.
Cell Research|June 19, 2023
An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progressionLiang Wu, Jiayan Yan, Yinqi Bai, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinomaMin Li, Yuxiao Tang, Dongyao Wang, et al.
Cancer Letters|April 20, 2024
Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinomaSongyang Yu, Sheng Su, Pengcheng Wang, et al.
Cell Death & Disease|May 12, 2018
microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7AChubin Luo, Dan Yin, Hao Zhan, et al.
Nucleic Acids Research|May 23, 2024
rAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombinationChen Ling, Chenghui Yu, Cong Wang, et al.
Hepatology (Baltimore, Md.)|December 26, 2024
LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinomaRongqi Sun, Kaixuan Liu, Siyuan Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2018
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled StudyZheng Wang, Zhenggang Ren, Yi Chen, et al.
Lancet (London, England)|October 22, 2025
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trialZheng Wang, Jia Fan, Shaolai Zhou, et al.
Gut|December 13, 2025
CD177<sup>+</sup> neutrophils drive extracellular matrix remodelling and HGF-alpha release in ALPPS-induced liver regenerationJiayan Yan, Ao Huang, Shiyu Zhang, et al.
Cell Research|June 19, 2023
An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progressionLiang Wu, Jiayan Yan, Yinqi Bai, et al.
Pageof 2